Key takeaways:
Wegovy (semaglutide) is a once-weekly injection for weight loss. It’s considered a glucagon-like peptide-1 (GLP-1) receptor agonist. Wegovy is no longer in shortage, but some people may still have difficulty filling their prescription.
There are two injectable Wegovy alternatives: Zepbound (tirzepatide) and Saxenda (liraglutide). Zepbound is also a weekly injection, while Saxenda is a daily injection.
There are also oral weight-loss medications available. Examples include Contrave (naltrexone / bupropion), Qsymia (phentermine / topiramate ER), and Xenical (orlistat).
If you’re having difficulty filling your Wegovy prescription, your prescriber can help you navigate potential alternatives. They’ll consider your health goals, preferences, and other factors.
Wegovy (semaglutide) belongs to a growing group of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. It’s administered as a once-weekly injection for weight loss. Because it works well to help people lose weight, Wegovy was difficult to find due to shortages.
The Wegovy shortage is officially over and the supply is starting to improve. But some people may still have difficulty filling their prescription due to insurance coverage changes or other reasons. So, what are your alternatives? Below, we cover five injectable and oral Wegovy alternatives your prescriber may consider for you.
Compared with the other Wegovy alternatives, Zepbound (tirzepatide) has a few similarities with Wegovy. It’s also a once-weekly injection, and it works in a similar but slightly different way. Wegovy mimics GLP-1, a gut hormone involved in digestion and appetite. But Zepbound also mimics a second hormone called glucose-dependent insulinotropic polypeptide (GIP).
Zepbound is likely the closest alternative to Wegovy in terms of weight loss. In fact, results from a recent clinical trial have shown greater weight loss with Zepbound compared to Wegovy. But these two medications are approved for different uses beyond weight loss. Your health history will help determine which one is right for you.
For instance, if you have heart disease, Wegovy is also approved to lower the risk of serious cardiovascular problems in certain people. Zepbound isn’t approved for this yet, but it could be in the future.
Zepbound, though, is approved for moderate-to-severe obstructive sleep apnea (OSA) while Wegovy is not.
Zepbound and Wegovy are both approved for adults. Wegovy is also approved for adolescents ages 12 and older. So, adolescents looking for a Wegovy alternative may need to consider a different option than Zepbound for now.
Similar to Wegovy, Zepbound comes in a single-use injection pen. But you can also access lower-cost Zepbound vials through options such as LillyDirect.
Saxenda (liraglutide) is another injectable GLP-1 agonist medication and Wegovy alternative. It works the same way as Wegovy, but Saxenda needs to be injected every day. And it doesn’t have the same cardiovascular risk reduction approval. But like Wegovy, Saxenda is also approved for adults and adolescents ages 12 and older.
If you switch from Wegovy to Saxenda, keep in mind that the injection pens work differently. Wegovy comes in a single-use injection pen, while Saxenda comes in a multidose pen. That means you’ll use the Saxenda pen for multiple doses, instead of throwing it away after you use it.
With Saxenda, you may not lose as much weight as you might with Wegovy. In a study comparing the two medications, people receiving Saxenda lost about 6% of their starting body weight, while people receiving Wegovy lost close to 16%.
Saxenda and Wegovy are made by the same manufacturer. But unlike Wegovy, Saxenda is still in shortage.
A natural boost: Medications such as Wegovy work by mimicking the effects of a gut hormone called glucagon-like peptide-1 (GLP-1). But did you know that there are foods and supplements that can increase GLP-1 naturally?
How to save: Glucagon-like peptide-1 (GLP-1) medications like Ozempic don’t need to break the bank. Explore ways to save on your prescription with this GLP-1 savings guide.
Knowing the risks: Compounded products can help people access certain medications, such as when they are in shortage. Learn more about potential risks before giving compounded semaglutide a try.
If you’re looking for an oral weight-loss option, your prescriber may consider Contrave. It’s an oral pill that contains two medications — naltrexone and bupropion — that work together to reduce hunger and manage cravings. Because of how it works, Contrave can be a good option if you experience emotional eating.
After the first week, you’ll take Contrave twice a day. The amount of weight loss people see with Contrave is usually 5% to 8% of their starting body weight. As with Wegovy, you may experience side effects such as nausea and vomiting, constipation, and diarrhea. But dry mouth, trouble sleeping, and higher blood pressure are also possible with Contrave.
Contrave may not be safe for certain people, including those with unmanaged high blood pressure and seizure disorders. Contrave can also interact with other medications, such as opioid medications used for pain. Review your full medication list and health history with your healthcare team before starting Contrave.
Another oral option is Qsymia (phentermine / topiramate ER). Qsymia is also a combination tablet. Each tablet contains phentermine (a stimulant) and topiramate (a seizure medication). Both of these medications lower your appetite to help you lose weight.
Qsymia is taken once a day in the morning. As with Wegovy, you’ll typically start at a low dose and work your way up. Depending on which dose they take long term, most people lose 5% to 10% of their body weight with Qsymia. This is similar to the potential weight loss with Contrave but less than with Wegovy.
Qsymia also has different side effects, risks, and interactions to consider. Common side effects include dry mouth, constipation, and feelings of numbness and tingling. You should typically avoid Qsymia if you have certain health conditions, including glaucoma or hyperthyroidism.
Qsymia is the only weight-loss medication with a mandatory risk management program. This is because it can harm a growing fetus. If you’re able to get pregnant, you need a negative pregnancy test before starting Qsymia. Monthly pregnancy tests and the use of effective birth control are also required to manage this risk.
Good to know: Phentermine, found in Qsymia, is also available on its own for weight loss (Adipex-P, Lomaira). But unlike Qsymia, it’s only approved for short-term use (up to 12 weeks).
Xenical (orlistat) is an oral capsule that’s taken for weight loss. Xenical requires a prescription. But its active ingredient is also available over the counter (OTC) at a lower dose (sold as Alli).
Xenical helps people lose weight by blocking the body’s ability to absorb fat when you eat.
Because of this, it should be taken with meals that contain fat. Unfortunately, this also results in unpleasant side effects — such as loose, oily, or fatty stools; gas; and oily spotting on underwear.
One study found that after taking Xenical for one year, people lost an average of 8.5% of their starting body weight. Again, this is similar to the potential weight loss with other oral options but less than with Wegovy.
Since Xenical blocks fat absorption, it can interfere with your ability to absorb certain vitamins from your food. So, your prescriber may recommend adding a multivitamin. Xenical can also interact with other medications that you take by mouth, such as thyroid pills. In this case, you may need to take your other medications at a different time from when you take Xenical.
If you’re unable to fill your Wegovy prescription, there are still effective options available. The best alternative for you depends on several factors, including:
Your health goals: Some medications, such as Zepbound, may also help with health conditions like OSA. Your prescriber can recommend options that align with your specific health needs.
Your preferences: If you prefer pills over injections (or vice versa), this can help narrow down your options. Oral medications such as Contrave or Qsymia may be convenient for some. But weekly injections such as Zepbound may be easier for others to manage.
Your medical history: Certain Wegovy alternatives may not be safe if you have health conditions such as heart disease, seizures, or hyperthyroidism. Your prescriber can help rule out options that may carry added risk.
Your insurance and cost: Coverage varies by plan. Some medications may be preferred over others or require a prior authorization. Most Wegovy alternatives have copay savings cards available to help you save money, with the exception of Saxenda. Qsymia and Xenical both have lower-cost generic versions available.
No matter which Wegovy alternative you consider, talk to your healthcare team before making a switch. They can help you determine which option fits your lifestyle, health needs, and treatment goals.
There is currently no OTC version of Wegovy. Wegovy is a prescription-only medication that must be prescribed by a licensed healthcare professional. The closest OTC alternative is Alli, which works differently and is less effective for weight loss. However, there are certain foods and supplements that may boost GLP-1 levels naturally.
There may be a pill form of Wegovy in the near future. A higher-dose oral version of semaglutide (the active ingredient in Wegovy) is currently under FDA review for weight loss. Oral semaglutide is already available as Rybelsus for Type 2 diabetes, but it doesn’t currently come in doses that are comparable to Wegovy.
Wegovy’s sister drug is Ozempic, which also contains semaglutide. While Wegovy is approved for weight loss, Ozempic is approved for Type 2 diabetes. Both are GLP-1 receptor agonists and work the same way in the body. But they’re prescribed for different uses and have different dosage schedules.
Wegovy (semaglutide) is an FDA-approved medication for weight loss. Even though it’s no longer in shortage, some people may have difficulty filling their Wegovy prescription for various reasons. So, you may be looking for potential Wegovy alternatives.
Zepbound (tirzepatide) and Saxenda (liraglutide) work in a similar way as Wegovy. Weight-loss pills, such as Contrave (naltrexone / bupropion) and Qsymia (phentermine / topiramate ER), are available but may not result in as much weight loss.
These Wegovy alternatives are all approved for weight loss or management. But, they work differently in your body and lead to varying amounts of weight loss. Your prescriber can work with you to determine which of these options may work best for you.
ClinicalTrials.gov. A study of tirzepatide (LY3298176) on the reduction on morbidity and mortality in adults with obesity (SURMOUNT-MMO). National Library of Medicine.
ClinicalTrials.gov. (2025). A study of tirzepatide (LY3298176) once weekly in adolescent participants who have obesity or overweight with weight-related comorbidities. National Library of Medicine.
Eli Lilly and Company. (2025). Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine.
FDA Drug Shortages. (2025). Liraglutide injection. U.S. Food and Drug Administration.
Finer, N., et al. (2000). One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. International Journal of Obesity.
Melson, E., et al. (2024). What is the pipeline for future medications for obesity? International Journal of Obesity.
Nalpropion Pharmaceuticals. (2025). Contrave extended release- naltrexone hydrochloride and bupropion hydrochloride tablet, extended release [package insert].
Novo Nordisk. (2025). FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity. PRNewswire.
Rubino, D. M., et al. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 Randomized Clinical Trial. JAMA.
Sherman, M. M., et al. (2016). Naltrexone/bupropion ER (Contrave). Pharmacy and Therapeutics.
Vivus. (2024). Qsymia- phentermine and topiramate capsule, extended release [package insert].
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.